Hepion Pharmaceuticals, Inc.
Price Action
Technical Summary
CONSOLIDATINGHepion Pharmaceuticals, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 56), indicating performance broadly in line with the market. Earnings growth of 97% provides fundamental context to the price action. Investors should exercise caution due to high volatility (241% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.06 | +14.86% | ABOVE |
| 50 SMA | $0.06 | +11.84% | ABOVE |
| 100 SMA | $0.05 | +26.39% | ABOVE |
| 150 SMA | $0.06 | +17.65% | ABOVE |
| 200 SMA | $0.06 | +13.14% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HEPA in an uptrend right now?
HEPA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is HEPA overbought or oversold?
HEPA's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.
Is HEPA outperforming the market?
HEPA has a Relative Strength (RS) Rating of 56 out of 99. HEPA is performing about average compared to the market.
Where is HEPA in its 52-week range?
HEPA is trading at $0.07, which is 27% of its 52-week high ($0.25) and 16% above its 52-week low ($0.03).
How volatile is HEPA?
HEPA has a Beta of 0.29 and 52-week volatility of 241%. It's less volatile than the S&P 500 - generally more stable.